Vir Biotechnology, Inc. financial data

Symbol
VIR on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
1800 Owens Street, Suite 900, San Francisco, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.06K % +44.8%
Debt-to-equity 32.3 % -21%
Return On Equity -38.9 % -11.3%
Return On Assets -32.8 % -18.4%
Operating Margin -791 % +0.35%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 137M shares +0.8%
Common Stock, Shares, Outstanding 137M shares +1.62%
Entity Public Float 746M USD -58.6%
Common Stock, Value, Issued 14K USD +7.69%
Weighted Average Number of Shares Outstanding, Basic 136M shares +1.58%
Weighted Average Number of Shares Outstanding, Diluted 136M shares +1.58%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 74.2M USD -13.9%
Cost of Revenue 845K USD -69.4%
Research and Development Expense 506M USD -12.6%
Costs and Expenses 661M USD -14.2%
Operating Income (Loss) -587M USD +14.2%
Nonoperating Income (Expense) 64.1M USD +14.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -523M USD +16.7%
Income Tax Expense (Benefit) -1.15M USD +91.2%
Net Income (Loss) Attributable to Parent -522M USD +15.1%
Earnings Per Share, Basic -3.83 USD/shares +16.6%
Earnings Per Share, Diluted -3.83 USD/shares +16.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 223M USD -7.71%
Marketable Securities, Current 678M USD -46.7%
Cash, Cash Equivalents, and Short-term Investments 1.19B USD -30%
Other Assets, Current 100K USD -98.7%
Assets, Current 1.04B USD -34.4%
Property, Plant and Equipment, Net 63.2M USD -34.2%
Operating Lease, Right-of-Use Asset 59.7M USD -16.2%
Intangible Assets, Net (Excluding Goodwill) 8.12M USD -64%
Goodwill 16.9M USD 0%
Assets 1.4B USD -27.1%
Accounts Payable, Current 5.08M USD -19.8%
Liabilities, Current 120M USD -31.8%
Deferred Income Tax Liabilities, Net 3.25M USD -82.4%
Operating Lease, Liability, Noncurrent 90.1M USD -19.3%
Other Liabilities, Noncurrent 14.6M USD -7.65%
Liabilities 248M USD -24.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.72M USD -111%
Retained Earnings (Accumulated Deficit) -760M USD -219%
Stockholders' Equity Attributable to Parent 1.97B USD -1.51%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 1.15B USD -27.7%
Liabilities and Equity 1.4B USD -27.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -109M USD +13%
Net Cash Provided by (Used in) Financing Activities 152K USD -93.5%
Net Cash Provided by (Used in) Investing Activities 28.4M USD -71%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 137M shares +1.62%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -80.8M USD -219%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 319M USD +22%
Deferred Tax Assets, Valuation Allowance 453M USD +27.1%
Operating Lease, Liability 97.9M USD -21.4%
Depreciation 14.2M USD -24.9%
Payments to Acquire Property, Plant, and Equipment 1.87M USD -72.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -523M USD +13.8%
Lessee, Operating Lease, Liability, to be Paid 124M USD -21%
Property, Plant and Equipment, Gross 100M USD -23.1%
Operating Lease, Liability, Current 7.75M USD -39.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 12.6M USD -23.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 12.6M USD -32.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 25.6M USD -19.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 12.9M USD -23.8%
Deferred Tax Assets, Operating Loss Carryforwards 180M USD +30.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 17.9M USD +32.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 13.3M USD -22.5%
Additional Paid in Capital 1.91B USD +4.54%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 133K USD 0%
Depreciation, Depletion and Amortization 18.3M USD +66.6%
Deferred Tax Assets, Net of Valuation Allowance 25.5M USD -37.8%
Share-based Payment Arrangement, Expense 78.5M USD -29.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%